224 related articles for article (PubMed ID: 19749786)
1. Increase in sphingolipid catabolic enzyme activity during aging.
Sacket SJ; Chung HY; Okajima F; Im DS
Acta Pharmacol Sin; 2009 Oct; 30(10):1454-61. PubMed ID: 19749786
[TBL] [Abstract][Full Text] [Related]
2. Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging.
Lightle SA; Oakley JI; Nikolova-Karakashian MN
Mech Ageing Dev; 2000 Dec; 120(1-3):111-25. PubMed ID: 11087909
[TBL] [Abstract][Full Text] [Related]
3. Human meconium contains significant amounts of alkaline sphingomyelinase, neutral ceramidase, and sphingolipid metabolites.
Duan RD; Cheng Y; Jönsson BA; Ohlsson L; Herbst A; Hellström-Westas L; Nilsson A
Pediatr Res; 2007 Jan; 61(1):61-6. PubMed ID: 17211142
[TBL] [Abstract][Full Text] [Related]
4. Functions of neutral ceramidase in the Golgi apparatus.
Sakamoto W; Coant N; Canals D; Obeid LM; Hannun YA
J Lipid Res; 2018 Nov; 59(11):2116-2125. PubMed ID: 30154232
[TBL] [Abstract][Full Text] [Related]
5. Measurement of ceramide and sphingolipid metabolism in tumors: potential modulation of chemotherapy.
Modrak DE
Methods Mol Med; 2005; 111():183-94. PubMed ID: 15911980
[TBL] [Abstract][Full Text] [Related]
6. Sphingomyelin metabolism is developmentally regulated in rat lung.
Longo CA; Tyler D; Mallampalli RK
Am J Respir Cell Mol Biol; 1997 May; 16(5):605-12. PubMed ID: 9160843
[TBL] [Abstract][Full Text] [Related]
7. Aerobic training in rats increases skeletal muscle sphingomyelinase and serine palmitoyltransferase activity, while decreasing ceramidase activity.
Błachnio-Zabielska A; Zabielski P; Baranowski M; Gorski J
Lipids; 2011 Mar; 46(3):229-38. PubMed ID: 21181285
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the sphingolipid signaling pathways in the growing and hypoxic rat heart.
El Alwani M; Usta J; Nemer G; El Sabban M; Nasser M; Bitar H; Souki R; Dbaibo GS; Bitar FF
Prostaglandins Other Lipid Mediat; 2005 Dec; 78(1-4):249-63. PubMed ID: 16303620
[TBL] [Abstract][Full Text] [Related]
9. Effects of flavonoids on sphingolipid turnover in the toxin-damaged liver and liver cells.
Babenko NA; Shakhova EG
Lipids Health Dis; 2008 Jan; 7():1. PubMed ID: 18226198
[TBL] [Abstract][Full Text] [Related]
10. Expression of intestinal and lung alkaline sphingomyelinase and neutral ceramidase in cystic fibrosis f508del transgenic mice.
Ohlsson L; Hjelte L; Hühn M; Scholte BJ; Wilke M; Flodström-Tullberg M; Nilsson A
J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):547-54. PubMed ID: 18955860
[TBL] [Abstract][Full Text] [Related]
11. CDase is a pan-ceramidase in Drosophila.
Yuan C; Rao RP; Jesmin N; Bamba T; Nagashima K; Pascual A; Preat T; Fukusaki E; Acharya U; Acharya JK
Mol Biol Cell; 2011 Jan; 22(1):33-43. PubMed ID: 21148295
[TBL] [Abstract][Full Text] [Related]
12. Fingolimod Affects Transcription of Genes Encoding Enzymes of Ceramide Metabolism in Animal Model of Alzheimer's Disease.
Jęśko H; Wencel PL; Wójtowicz S; Strosznajder J; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2020 Jun; 57(6):2799-2811. PubMed ID: 32356173
[TBL] [Abstract][Full Text] [Related]
13. Acid and neutral sphingomyelinase, ceramide synthase, and acid ceramidase activities in cutaneous aging.
Jensen JM; Förl M; Winoto-Morbach S; Seite S; Schunck M; Proksch E; Schütze S
Exp Dermatol; 2005 Aug; 14(8):609-18. PubMed ID: 16026583
[TBL] [Abstract][Full Text] [Related]
14. Ceramidases, roles in sphingolipid metabolism and in health and disease.
Coant N; Sakamoto W; Mao C; Hannun YA
Adv Biol Regul; 2017 Jan; 63():122-131. PubMed ID: 27771292
[TBL] [Abstract][Full Text] [Related]
15. Differential branching of the sphingolipid metabolic pathways with the stage of development. Involvement of sphingosine kinase.
Facchinetti MM; Beuret C; Marquez MG; Sterin-Speziale N
Biol Neonate; 2003; 84(3):243-51. PubMed ID: 14504448
[TBL] [Abstract][Full Text] [Related]
16. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space.
Tani M; Ito M; Igarashi Y
Cell Signal; 2007 Feb; 19(2):229-37. PubMed ID: 16963225
[TBL] [Abstract][Full Text] [Related]
17. Sphingolipids and response to chemotherapy.
Dimanche-Boitrel MT; Rebillard A
Handb Exp Pharmacol; 2013; (216):73-91. PubMed ID: 23563652
[TBL] [Abstract][Full Text] [Related]
18. Effect of Empagliflozin on Sphingolipid Catabolism in Diabetic and Hypertensive Rats.
Pérez-Villavicencio R; Flores-Estrada J; Franco M; Escalante B; Pérez-Méndez O; Mercado A; Bautista-Pérez R
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270028
[TBL] [Abstract][Full Text] [Related]
19. Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.
Canals D; Perry DM; Jenkins RW; Hannun YA
Br J Pharmacol; 2011 Jun; 163(4):694-712. PubMed ID: 21615386
[TBL] [Abstract][Full Text] [Related]
20. Effects of inhibitors of key enzymes of sphingolipid metabolism on insulin-induced glucose uptake and glycogen synthesis in liver cells of old rats.
Babenko NA; Kharchenko VS
Biochemistry (Mosc); 2015 Jan; 80(1):104-12. PubMed ID: 25754045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
